Stevanato Group (STVN)
(Delayed Data from NYSE)
$19.97 USD
-0.18 (-0.89%)
Updated May 24, 2024 04:00 PM ET
After-Market: $19.94 -0.03 (-0.15%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
STVN 19.97 -0.18(-0.89%)
Will STVN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for STVN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STVN
USNA vs. STVN: Which Stock Should Value Investors Buy Now?
USNA or STVN: Which Is the Better Value Stock Right Now?
STVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Stevanato Group (STVN) to Report Q1 Results: What You Should Expect
TAK or STVN: Which Is the Better Value Stock Right Now?
Other News for STVN
Stevanato Group Announces Results of Annual General Meeting
Stevanato Group’s AGM: All Resolutions Approved
Stevanato Group to Present at Upcoming Investor Conferences
Stevanato Group Navigates Q1 Challenges, Eyes Long-Term Growth
Warning: STVN is at high risk of performing badly